.
The occurrence of synovial fluid cryoproteins was first described by Marcus and Townes (1971) and subsequently by Cracchiolo et al. (1971) . The synovial fluid cryoproteins of rheumatoid arthritis were well characterised and were shown to consist of mixed immunoglobulins, rheumatoid factor, antinuclear antibody, fibrinogen, and small amounts of DNA. Rheumatoid synovial fluid cryoproteins were found to have significant complement fixing activity which resided in the 19S region, whereas nonrheumatoid synovial fluid cryoproteins were devoid of such activity (Marcus and Townes, 1971) .
The significance of cold insoluble proteins in the rheumatoid synovial fluid is unclear. There is speculation that the cryoproteins represent soluble antigen-antibody complexes, as described in the serum of patients with lupus nephritis (Winfield et al., 1975) and that they play a role in synovial inflammation. Although IgM with antiglobulin activity is found complexed with IgG in rheumatoid joint fluid, it is not clear whether that reaction is the initial event in the synovitis or merely an epiphenomenon.
Accepted for publication 4 Little attention has been paid to the cryoproteins of other joint disorders, such as gout, osteoarthritis, Reiter's syndrome, and psoriatic arthritis. Immune complexes have not been implicated in the arthritis of the so-called rheumatoid variants (Bunch et al., 1974) , but there has been no other suitable explanation for the intense inflammation often seen with those diseases.
The purpose of this study was further to expand the investigation of cryoproteins in various rheumatic conditions, including seronegative arthritides and acute nonspecific polyarthritis, and to compare those findings to that of rheumatoid arthritis. The cold insoluble proteins were characterised as to their immunoglobulin content and presence of complement and rheumatoid factor activity and to evaluate their occurrence in relation to the degree of synovial inflammation.
Materials and methods
Seventy-four synovial fluids were obtained from 65 patients with diagnoses of definite or classical rheumatoid arthritis (18), acute gout with sodium urate crystals (7), psoriatic arthritis (4), Reiter's syndrome (6), gonococcal arthritis (4), osteoarthritis (17) , systemic lupus erythematosus (1), and acute nonspecific inflammatory polyarthritis (8).
Any patient who developed arthritis of less than 6 weeks' duration and did not fall in any definite diagnostic category was termed acute nonspecific polyarthritis. Serial synovial fluids were occasionally obtained from the same patient.
After aspiration the synovial fluid was immediately placed in warmed plain glass tubes and incubated for at least 1 hour at 370C. Hyaluronidase (Wyeth) 0 1 unit per ml of synovial fluid was added to the synovial fluid and mixed. The tube was centrifuged at room temperature and the supernatant was placed in 5 ml aliquots at 40C for 5 days for maximum cryoprecipitation. In addition synovial fluid was placed in Wintrobe tubes at 40C for 5 days, spun at 2500 rpm for 10 minutes at 40C and read to determine the cryocrit.
The synovial cryoprecipitate was solubilised by the technique of Weisman and Zvaifler (1975) as follows: 5 ml of the synovial fluid was spun at 2500 rpm for 10 minutes at 40C. The supernatant was removed and stored at 40C. A volume of cold normal saline equal to the volume of the original fluid was added to the cryoprotein button, mixed thoroughly, and respun at 2500 rpm for 10 minutes at 40C. The procedure was repeated 3 times. To resolubilise the cryoprotein, 0 5 ml of 0*3 M NaCl was added to the washed cryoprotein button and incubated for one hour at 370C. Then 0 5 ml of distilled water was added and the solution was reincubated for 1 hour at 370C. The final 1 ml volume in normal saline (0O 15 M) was centrifuged at room temperature, and any insoluble material was discarded. Further immunochemical tests were performed at room temperature.
The resolubilised cryoprecipitate was subjected to immunoelectrophoresis (1 % agarose, pH 8 6) with antisera monospecific for human immunoglobulin IgG, IgA, IgM, fibrinogen, C'3, and for whole human serum (Miles Laboratory). Antiglobulin activity was measured at room temperature by latex agglutination and positive samples were titrated by the method of Singer and Plotz (1956) . Total protein concentration of the solubilised cryoprecipitates was measured by the method of Lowry et al. (1951) , except that sodium citrate was used in place of sodium tartrate to provide a more stable reagent. The protein concentration of the final solution, expressed as mg/dl, represented a concentration of 5 times with respect to the initial sample volume.
Synovial fluid leucocyte count was performed by standard techniques on fresh synovial fluid collected in heparinised tubes.
Results
Visible protein-containing cryoprecipitates were detected in 73 of 74 synovial fluids examined. Characterisation of the cryoproteins revealed that most patients (40/57) with inflammatory arthritis, that is, rheumatoid arthritis, gout, Reiter's syndrome, systemic lupus erythematosus, and gonococcal arthritis, had qualitatively detectable TgG and occasionally TgM (Table 1) . Patients with noninflammatory effusions only occasionally (4/17) had IgG detected.
Cryocrit determinations on the synovial fluid cryoprecipitates revealed that all values were less than 2-0%. There did not appear to be any significant differences between the inflammatory and noninflammatory groups.
The immunoglobulin content of synovial fluid cryoproteins varied within the inflammatory arthritis Psoriasis  PSI  PS2  PS3  PS4  PS5  PS6  PS7  Gout  GI  G2  G3  G4  G5  G6  G7  Gonococcal   infection  GI  G2  G3  G4  G5   DJD   DI  D2  D3  D4  D5  D6  D7  D8  D9   DIO  Dll  D12  D13  D14  D15  D16 The synovial fluids cryoproteins were examined for other components. In all samples, C'3 was not detected. Fibrinogen was intermittently present but was detected in somewhat higher frequency in inflammatory than noninflammatory synovial fluid cryoproteins. Rheumatoid factor activity in the rheumatoid arthritis synovial cryoprecipitates was present in 4 samples. Serum rheumatoid factor comparisons were generally not available because the Singer-Plotz method was not used. In the nonrheumatoid inflammatory diseases the latex fixation tests were uniformly negative despite that IgM was occasionally detected.
Measurement of the protein concentration of the synovial fluid cryoproteins (Table 2) revealed that the highest values occurred in Reiter's syndrome followed by rheumatoid arthritis, gout, nonspecific polyarthritis, and psoriatic arthritis. The lowest values tended to occur with the osteoarthritis group, consistent with the low incidence of any immunoglobulin detection. It was felt that immunoglobulins made up the greatest portion of the cryoprotein measured although serum proteins, such as fibrinogen, were occasionally detected.
In examining the relationship between the leucocyte count of the synovial fluid and the IgM, IgG, and IgA content of the cryoglobulin (Fig. 1 ), significant differences were noted between the 3 groups. (P<0 00l by the F test). The mean synovial fluid leucocyte count for the cryoproteins with IgG and IgM was 22 320/mm3 (22 x 109/l) compared to 16 310/mm3 (16 x 109/l) for IgG cryoproteins and 4680/mm3 (4 7 x 109/l) for cryoproteins without detectable immunoglobulin. Two-way comparison tests showed that immunoglobulin complexes of IgG-IgM or IgG alone were significantly associated with higher synovial fluid leucocyte counts (P<0 01) 
Discussion
The purpose of these studies was to survey synovial fluids in a variety of rheumatic conditions for the presence and character of cryoproteins. With the methods outlined virtually all synovial fluids examined yielded some cryoprecipitable material. As demonstrated by Cracchiolo et al. (1971) and Marcus and Towers (1971) , rheumatoid arthritis fluid cryoproteins contain immunoglobulin IgG and/or 1gM. However, careful examination in our study of psoriatic, Reiter's syndrome, gout, and acute nonspecific polyarthritis revealed similar immunoglobulin findings. The major differences were the less frequent detection of IgM and the absence of any antigammaglobulin activity in the latter diseases. Osteoarthritis fluids were occasionally found to yield immunoglobulin in small amounts despite the noninflammatory nature of the diseases.
In examining the magnitude of inflammation and cryoprotein concentration we found that psoriatic and Reiter's syndrome fluids showed inflammatory values equal to those of rheumatoid arthritis. In fact, the mean cryoprotein concentration for Reiter's syndrome was higher than rheumatoid arthritis. Pekin and Zvaifler (1964) showed that Reiter's syndrome synovial fluids were high in total synovial fluid protein values, leucocyte counts, and total haemolytic complement values.
An interesting aspect of this study was the presence of synovial fluid cryoglobulins in rheumatic diseases not generally considered to involve immunologic mechanisms. As described, Reiter's syndrome, psoriatic, gout, and gonococcal arthritis fluids contained immunoglobulin IgG or occasionally IgM. Hunder et al. (1977) showed that the same rheumatic conditions were associated with in-vitro activation of C3 and/or factor B in their joint fluids. In addition, there was a positive correlation between the amount of C3 conversion and synovial (Ruddy et al., 1972) . Evidence supporting the role of immune complexes in psoriatic and Reiter's syndrome synovial fluids is still lacking. Since the magnitude of the inflammatory process of the nonrheumatoid conditions, apart from osteoarthritis, appeared to be proportional to the concentration of immunoglobulin, the synovial fluid cryoprotein may simply be another index of inflammation along with the leucocyte count, volume of exudative fluid, total protein concentration (Ropes and Bauer, 1953) , and total haemolytic complement (Pekin and Zvaifler, 1964) . In generalised joint inflammation large protein molecules are found in joint fluid in greater amounts than when the synovial membranes are not inflammed. As a result of this phenomenon cryoprecipitable protein is more likely to be detected in inflammatory fluids. Although total protein concentration of the synovial fluid was not measured, our synovial fluid cryoprotein measurements seem to parallel the protein measurements of the studies by Pekin and Zvaifler (1964) . In our study the cryoprecipitable protein concentration was higher by 5 to 10 fold than Marcus and Townes (1971) and Cracchiolo et al. (1971) found. This may be attributed to differences in techniques of harvesting cryoproteins and a higher concentration ratio of final solution to initial volume rather than to the collection of more inflammed joint fluids found in earlier reports. 
